Management tracks

Rare disease company Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Mary Szela as CEO. Sandford Smith had been interim CEO since Marc Beer's resignation in July 2015. Szela was

Read the full 275 word article

How to gain access

Continue reading with a
two-week free trial.